Gianluca Iacobellis, MD PhD
University of Miami
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gianluca Iacobellis, MD PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:21 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT04341935 · Effects of DPP4 Inhibition on COVID-19University of Miami · withdrawn · Coronavirus Infection, Type 2 Diabetes · principal investigator
- N/ANCT04200625 · Semaglutide vs Dulaglutide on Epicardial Adipose TissueUniversity of Miami · completed · Epicardial Fat · principal investigator
- Ph4NCT03260881 · Liraglutide Effects on Epicardial Fat Inflammatory GenesUniversity of Miami · completed · Type2 Diabetes, Coronary Artery Disease · principal investigator
- Ph4NCT02235298 · Dapagliflozin Effects on Epicardial FatUniversity of Miami · completed · Type 2 Diabetes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:21 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.